Mar 12, 01
|
| 14:00 ET |
Trega Biosciences Announces Stockholder Approval Of Merger With LION bioscience
|
|
Feb 06, 01
|
| 21:18 ET |
Trega Biosciences Announces Date for Special Meeting of Stockholders
|
|
Jan 16, 01
|
| 08:03 ET |
Trega Biosciences Expands iDEA(TM) Licensing Agreement With Roche
|
|
Dec 13, 00
|
| 08:02 ET |
Trega Biosciences Licenses iDEA(TM) Absorption Module to Tibotec Group; Trega's Drug Discovery Products Appeal to Emerging Pharmaceutical Company
|
|
Dec 08, 00
|
| 09:00 ET |
Trega Biosciences, Inc. Invites You to Join Its Virtual CEO Summit Webcast
|
|
Dec 06, 00
|
| 11:00 ET |
Trega Biosciences, Inc. Invites You to Join Its Virtual CEO Summit Webcast
|
|
Nov 09, 00
|
| 07:59 ET |
Trega Biosciences Reports Third-Quarter 2000 Results
|
|
Oct 26, 00
|
| 08:08 ET |
Shift to In Silico Methods for Drug Discovery Highlighted at Largest Worldwide Gathering of Pharmaceutical Scientists
|
|
Oct 12, 00
|
| 09:59 ET |
Trega Biosciences Announces Janssen Research Foundation and The R.W. Johnson Pharmaceutical Research Institute License iDEA(TM) Predictive Models
|
|
Oct 04, 00
|
| 08:05 ET |
Trega Biosciences Signs Agreement for its Chem.Folio(R) Chemistry Services to Enhance PhycoGen's Discovery Programs
|
|
Sep 21, 00
|
| 08:00 ET |
Trega Biosciences Licenses Its iDEA(TM) Predictive Model to Aventis Pharma AG
|
|
Aug 15, 00
|
| 07:02 ET |
Trega Biosciences Launches Enhanced Version of Its iDEA(TM) Predictive Model for Drug Absorption
|
|
Aug 03, 00
|
| 17:02 ET |
Trega Biosciences Reports Second Quarter 2000 Results
|
|
Jul 25, 00
|
| 08:11 ET |
Trega Biosciences' IDEA(TM) Predictive Model Licensed by Roche Following Successful Validation Study
|
|
May 11, 00
|
| 08:02 ET |
Trega Biosciences and Boehringer Ingelheim Agree to Second Custom Synthesis Deal
|
|
May 10, 00
|
| 08:01 ET |
Trega Biosciences Reports First Quarter 2000 Results
|
|
Apr 05, 00
|
| 08:01 ET |
Trega Biosciences Announces $11 Million Private Placement
|
|
Mar 22, 00
|
| 08:01 ET |
Trega Biosciences Announces New Board Member
|
|
Feb 14, 00
|
| 08:09 ET |
Trega Biosciences and Discovery Technologies Ltd. Form Alliance
|
|
Feb 11, 00
|
| 07:00 ET |
Trega Biosciences Announces Strategic Focus on Information-Based Products
|
|
Feb 07, 00
|
| 08:07 ET |
Trega Biosciences Reports Year-end and Fourth Quarter 1999 Results; Annual Revenues Increase 24%; Loss Decreases 32%
|
|
Jan 19, 00
|
| 08:00 ET |
Trega Biosciences and EVOTEC BioSystems Form Strategic Alliance
|
|
Jan 13, 00
|
| 08:26 ET |
Trega Announces Preliminary Revenue Results and New Chem.Folio Customers
|
|
Jan 11, 00
|
| 11:34 ET |
Trega Biosciences and Boehringer Ingelheim Sign Agreement for Custom Synthesis
|
|
Jan 06, 00
|
| 16:12 ET |
Dupont Becomes a Trega Biosciences Chem.Folio Customer
|
|
Dec 16, 99
|
| 08:00 ET |
Trega Announces Completion of Development Of The IDEA Simulation System for Drug Absorption
|
|
Dec 09, 99
|
| 18:30 ET |
Harvard Apparatus and Trega Biosciences Announce Harvard's Acquisition of the Diffusion Chamber Systems Product Line from Trega Biosciences
|
|
Dec 08, 99
|
| 08:02 ET |
Guru.com and Webhire, Inc. Form Strategic Business Partnership
|
|
| 08:02 ET |
Trega Biosciences Announces Board Changes
|
|
Dec 02, 99
|
| 08:00 ET |
Trega Biosciences Appoints Chief Information Officer
|
|
Nov 03, 99
|
| 08:01 ET |
Trega Biosciences Reports Third-Quarter 1999 Results; Revenues Increase 54% Over Previous Quarter
|
|
Oct 14, 99
|
| 08:02 ET |
Trega Announces Expanded R&D Collaboration With Novartis
|
|
Sep 30, 99
|
| 07:31 ET |
Trega Biosciences Announces Management Addition and New Business Developments
|
|
Sep 02, 99
|
| 08:31 ET |
Trega Announces the Achievement of IDEA Milestone; In Silico Model to Accelerate Drug Development
|
|
Aug 25, 99
|
| 08:31 ET |
Trega Biosciences Announces Resignation of Board Member
|
|
Aug 23, 99
|
| 08:31 ET |
Trega Biosciences Forms A Strategic Relationship With ChemNavigator.com
|
|
Aug 10, 99
|
| 08:32 ET |
Trega Biosciences Reports Second-Quarter 1999 Results
|
|
Jun 21, 99
|
| 08:31 ET |
Trega Biosciences Appoints Chief Commercial Officer
|
|
May 04, 99
|
| 08:31 ET |
Trega Biosciences Reports First-Quarter Results; Revenues Increase 75%
|
|
Apr 07, 99
|
| 08:30 ET |
Trega Biosciences Announces Positive Results of HP 228 in a Phase II Post-operative Pain Study
|
|
Mar 24, 99
|
| 08:31 ET |
NaviCyte, a Trega Biosciences Company, Announces Signing the R.W. Johnson Pharmaceutical Research Institute as the Newest Member of its Idea Pk-Informatics Consortium
|
|
Mar 11, 99
|
| 08:31 ET |
Trega Biosciences Reports Year-End and Fourth-Quarter 1998 Results
|
|
Mar 09, 99
|
| 08:30 ET |
NaviCyte, a Trega Biosciences Company, Signs Schering-Plough to Its IDEA Pk-Informatics Consortium
|
|
Mar 04, 99
|
| 08:30 ET |
Isis Pharmaceuticals Purchases Trega's Chem.Folio Combinatorial Libraries
|
|
Jan 12, 99
|
| 08:32 ET |
Trega Biosciences Appoints Chief Financial Officer
|
|
Dec 02, 98
|
| 16:00 ET |
Warner-Lambert becomes Trega's Chem.Folio Partner
|
|
Nov 13, 98
|
| 08:00 ET |
Trega Biosciences Announces Acquisition of NaviCyte, Inc.
|
|
Nov 12, 98
|
| 08:31 ET |
Trega Biosciences Announces Appointment of Michael G. Grey as Chief Executive Officer
|
|
Nov 11, 98
|
| 08:30 ET |
Trega Biosciences Reports Third-Quarter 1998 Results
|
|
Nov 10, 98
|
| 08:31 ET |
Trega Exercises Stock Put Option With Novartis; Receives $7 Million in Exchange for Common Stock
|
|
Oct 21, 98
|
| 08:31 ET |
Trega Announces That ChromaXome is Granted Two U.S. Patents in Combinatorial Biology
|
|
Oct 05, 98
|
| 08:31 ET |
Biogen Becomes Trega's First Chem.Folio Customer;
|
|
Sep 30, 98
|
| 08:30 ET |
Trega Ends Phase I Dose-Escalation Trial of HP 228; Study Shows Systemic Absorption of HP 228 Following Administration to Lung
|
|
Aug 14, 98
|
| 08:31 ET |
Trega Biosciences Reports Second-Quarter 1998 Results
|
|
Jul 15, 98
|
| 08:30 ET |
Trega Biosciences Meets Ono Benchmark
|
|
Jul 09, 98
|
| 07:30 ET |
Trega Biosciences Adds Vice President of Biological Research & Development Stephen F. Flaim, Ph.D. Joins Trega
|
|
Jun 24, 98
|
| 05:30 ET |
Trega Biosciences Chief Executive Accepts New Position; Robert S. Whitehead to Remain as Trega's Chairman
|
|
Jun 15, 98
|
| 07:30 ET |
Trega Biosciences to Present at BIO '98 Investor and Partnering Conference
|
|
May 26, 98
|
| 08:37 ET |
Novartis and Trega Establish R&D Collaboration
|
|
May 15, 98
|
| 09:01 ET |
Trega Biosciences Reports First-Quarter 1998 Results
|
|
May 14, 98
|
| 16:00 ET |
Trega Biosciences and IRORI Enter Into Licensing Agreement; Trega to Provide Commercial License to Chemical Synthesis Technology
|
|
| 16:00 ET |
Trega and Ono Expand R&D Partnership Trega To Optimize and Screen Ono Lead Compounds
|
|
May 08, 98
|
| 09:00 ET |
Trega Biosciences Reaches Milestone In Procter & Gamble Deal; Trega Chemistry Used to Discover Lead Compounds
|
|
Apr 13, 98
|
| 09:00 ET |
Trega Initiates Phase I Study of HP 228 Using Spiros(R) Inhaler
|
|
Feb 12, 98
|
| 16:01 ET |
Warner-Lambert Identifies Lead Compounds From Trega Combinatorial Libraries
|
|
| 10:11 ET |
Trega and Ono Sign Letter of Intent to Expand R&D Relationship; Trega to Optimize and Screen Ono Lead Compounds
|
|
Feb 09, 98
|
| 16:03 ET |
Trega Biosciences Announces Management Appointments
|
|
Jan 26, 98
|
| 09:02 ET |
Trega Biosciences and Torrey Pines Institute for Molecular Studies To Discontinue Research Collaboration
|
|
Jan 13, 98
|
| 09:30 ET |
Trega Biosciences to Present at the Hambrecht & Quist 16th Annual Healthcare Conference
|
|
Nov 12, 97
|
| 09:00 ET |
Trega Biosciences Reports Third-Quarter 1997 Results
|
|
Sep 16, 97
|
| 09:00 ET |
Trega Biosciences Appoints Dr. Lawrence Muschek President of R&D And to the Board
|
|
Aug 21, 97
|
| 08:03 ET |
Trega Biosciences Resolves Suit
|
|
Aug 14, 97
|
| 07:02 ET |
Trega Biosciences Discontinues Clinical Development of HP 228 in Diabetes, Obesity and Chemotherapy-Induced Toxicity, But Continues In Pain
|
|
| 07:01 ET |
Trega Biosciences Initiates Phase II Trial for Post-Surgical Pain
|
|
| 07:00 ET |
Trega Biosciences Reports Second-Quarter 1997 Results
|
|
Jun 19, 97
|
| 07:02 ET |
Trega Licenses Patents From Northwest Neurologic
|
|
Jun 12, 97
|
| 16:00 ET |
Trega Elects Levin and Wiklund to Board; New Directors Expand Corporate Development and Operational Expertise
|
|
Jun 11, 97
|
| 07:03 ET |
Trega and Ono Establish R&D Partnership
|
|
Jun 06, 97
|
| 08:00 ET |
Dr. Fariba Ghodsian Joins Trega Biosciences; Biotech Analyst Becomes Strategic and Financial Advisor
|
|
May 30, 97
|
| 08:01 ET |
Trega Establishes Discovery Collaboration With Chiroscience Agreement Focuses on Novel Inflammatory Inhibitors
|
|
May 15, 97
|
| 18:54 ET |
Trega Biosciences Reports First-Quarter 1997 Results
|
|
May 05, 97
|
| 16:30 ET |
Trega Biosciences and TPIMS Extend Combinatorial Chemistry Agreement
|
|
Apr 15, 97
|
| 16:30 ET |
Houghten Pharmaceuticals to Change Name to Trega Biosciences, Inc.; The Company Will Trade Under the Nasdaq Symbol TRGA
|
|
Mar 03, 97
|
| 16:00 ET |
Houghten Finalizes Sale of Peptide Subsidiary; Proceeds to be Used for Ongoing Technology Expansion
|
|
Feb 24, 97
|
| 17:42 ET |
Houghten Pharmaceuticals Reports Year-End and Fourth-Quarter 1996 Results
|
|
Feb 21, 97
|
| 07:00 ET |
Houghten Debuts Corporate Web Site; Provides Easy Access to Multiple Drug Discovery Sites
|
|
Jan 17, 97
|
| 07:00 ET |
Houghten's Lead Compound May Utilize Newly Discovered Signaling Pathway
|
|
Jan 08, 97
|
| 07:02 ET |
Houghten and Chugai Biopharmaceuticals Initiate Drug Discovery Collaboration and License Agreement
|
|
Dec 19, 96
|
| 16:30 ET |
Tuttle Retires as Houghten Pharmaceuticals' Chief Scientific Officer
|
|
Dec 03, 96
|
| 08:31 ET |
Houghten Pharmaceuticals Reports Clinical Data First Study of HP 228 in Obese, Type II Diabetics Demonstrates Safety
|
|
Nov 14, 96
|
| 08:30 ET |
Houghten Pharmaceuticals Reports Third-Quarter 1996 Results
|
|
| 08:30 ET |
Houghten Pharmaceuticals to Sell MPS Subsidiary Company Founder to Head New Entity; Remains As Houghten Board Member
|
|
Oct 11, 96
|
| 08:31 ET |
Houghten Pharmaceuticals Named in Complaint
|
|
Sep 26, 96
|
| 08:05 ET |
Houghten Pharmaceuticals Receives Stock in Exchange for Royalty Interest in Magainin's Lead Compound
|
|
Sep 17, 96
|
| 11:30 ET |
Torrey Pines Institute Receives Patent for Combinatorial Chemistry Approach; Technology Licensed to Houghten Pharmaceuticals
|
|
Aug 13, 96
|
| 16:04 ET |
Houghten Pharmaceuticals Reports Second Quarter 1996 Results
|
|